Trial intelligence / Profile preview

SAFE-PLASMA: Freeze-Dried Plasma vs Conventional Plasma in Adults

NCT07840352Phase 4Not yet recruiting

Sponsor
Teleflex
Start
Oct 2027
Primary completion
Apr 2031
01

Overview

A Phase 4 trial of EZPLAZ in coagulopathy, hemorrhage, sponsored by Teleflex. Planned start Oct 2027; status: not yet recruiting.

02

Drugs

EZPLAZ
03

Conditions

coagulopathyhemorrhage

Beyond the preview

Go deeper on NCT07840352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07840352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call